obesity therapeutics (Ligand/Institute Pasteur)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameobesity therapeutics (Ligand/Institute Pasteur)
Drug Alias Nameleptin gene (Ligand/Pasteur)
ClassificationBiologics
Mechanisms of ActionLeptin modulators
TargetsUpdating
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited KingdomFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLigand Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsObesity

Other Information

ATC CodeN/A
Related LinksN/A